SEC Form 4 · accession 0001354488-15-005343
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wei (William) Cao
Officer — Chief Executive Officer · Director
Period of report
Nov 16, 2015
Accepted (ET)
Nov 30, 2015 · 7:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 16, 2015 | S | 12,066 | $23.55 | D | 210,452 | D | |
| Common Stock | Nov 17, 2015 | S | 14,749 | $25.53 | D | 195,703 | D | |
| Common Stock | Nov 18, 2015 | S | 11,231 | $22.83 | D | 184,472 | D | |
| Common Stock | Nov 19, 2015 | S | 10,000 | $21.15 | D | 174,472 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.